EMI testing is the set of measurements that confirm a medical device neither emits electromagnetic energy that disrupts nearby equipment nor malfunctions when exposed to electromagnetic disturbances in its use environment. It covers emissions and immunity, and for medical electrical equipment, it follows IEC 60601-1-2, the EMC collateral standard.
What is EMI testing?
Electromagnetic interference (EMI) is unwanted electromagnetic energy that couples into an electronic circuit and degrades its function. EMI testing is the practical arm of electromagnetic compatibility (EMC) assessment: it measures what a device radiates and conducts, and how well the device keeps working when the environment radiates back at it. Every powered medical device, from an infusion pump to a patient monitor, has to coexist with Wi-Fi, cellular signals, motors, and other equipment in a clinical space.
Two halves make up the discipline. Emissions testing checks that the device stays below defined limits so it does not interfere with others. Immunity testing checks that the device tolerates a specified level of interference without losing what the standards call essential performance. A device passes only when both sides hold.
Why EMI testing matters in medical device development
An unmanaged EMI failure is a patient-safety event. A ventilator that resets near an electrosurgical unit, or a monitor that shows a false reading in a high-field environment, can cause direct harm. Regulators treat EMC as a basic safety property, not a nice-to-have.
Evidence of EMI testing is expected in a regulatory submission. The FDA’s June 2022 guidance, Electromagnetic Compatibility (EMC) of Medical Devices, tells reviewers what to look for in a 510(k), De Novo, PMA, or IDE, and it now covers in vitro diagnostic products too. Under EU MDR 2017/745, EMC sits within the general safety and performance requirements. Skipping or under-scoping the testing usually surfaces late—after design freeze, during submission review, or in a field complaint. Each of those points is far more expensive to fix than the test itself.
How EMI testing works
EMI testing runs against a plan derived from the device’s intended use environment, which IEC 60601-1-2 sorts into professional healthcare, home healthcare, and special environments such as ambulances. The core test suite includes:
- Radiated and conducted emissions, measured against CISPR 11 limits, to cap what the device puts into the air and onto the mains.
- Radiated RF immunity, including proximity fields from wireless transmitters like phones and tablets held close to the device.
- Electrostatic discharge (ESD) simulates a static shock from a person touching the device.
- Electrical fast transients, surges, and voltage dips on the power and signal lines.
- Conducted RF immunity and magnetic field immunity, using the IEC 61000-4 series test methods.
The current normative EMC standard for medical electrical equipment is IEC 60601-1-2:2014 with Amendment 1:2020, together known as Edition 4.1. Its defining feature is that test levels and pass criteria are tied to the manufacturer’s risk management file under ISO 14971. The team defines essential performance first and then proves that the device maintains it under electromagnetic stress. Formal testing is usually performed in an accredited EMC laboratory with a shielded chamber, while early bench testing and pre-compliance screening help identify problems before the formal test run.
Common challenges and best practices
The most common mistake is treating EMI testing as a final gate rather than a design input. Teams that wait until the end often fail on radiated emissions and then face a redesign of shielding, filtering, grounding, the enclosure, or the PCB. Conducting pre-compliance screening during development is cheaper and faster because potential EMC failures can be corrected before the design is locked.
Defining essential performance loosely is another frequent trap. If the term is vague, the test lab cannot judge pass or fail, and reviewers push back. Write it in measurable terms early. Cabling and grounding decisions made for mechanical convenience can wreck an otherwise clean design, so bring EMC thinking into layout and enclosure reviews. Keep the EMC test plan, the risk file, and the labeling aligned, because a reviewer will read all three together.
Frequently asked questions
EMC (electromagnetic compatibility) is the goal: a device coexisting with its electromagnetic environment. EMI testing is how you measure it, covering both the interference a device emits and its immunity to interference from others. In practice, the terms are used interchangeably, but EMC is the property and EMI testing is the verification activity that demonstrates it.
For medical electrical equipment, the governing standard is IEC 60601-1-2, the EMC collateral standard to IEC 60601-1. The current version is Edition 4.1, meaning the 2014 fourth edition plus Amendment 1 from 2020. It references CISPR 11 for emissions and the IEC 61000-4 series for immunity test methods, and ties acceptance criteria to the device’s risk management file.
Formal EMI testing happens on a production-equivalent device, usually before design freeze and ahead of a regulatory submission. Good teams start much earlier with pre-compliance screening during prototyping, because emissions and immunity problems often need changes to shielding, grounding, or the PCB. Finding them late means costly rework after the enclosure and layout are fixed.
Yes. The FDA’s 2022 EMC guidance explicitly extended its scope to include in vitro diagnostic products with electrical or electronic functions. An IVD analyzer with sensors and electronics has to show the same emissions and immunity performance as any other powered medical device, scaled to its own intended use environment and essential performance definition.
